Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients' lives.
anaheimbio.comLeiden, the NetherlandsBiotech
5 sources · checked 1 time, last 1h ago
Sources agree on the Series A, €40 million amount, date, financing participants, and headquarters. No source identifies a lead investor or states a valuation or financing total.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | $44.9M €40 million | 2026-11-05 | not stated | 5 outlets. #42 in Trending |
5 sources · checked 1 time, last 1h ago [ VERIFIED · CORRECTED ] read against 4 of 5 sources Sources agree on the Series A, €40 million amount, date, financing participants, and headquarters. No source identifies a lead investor or states a valuation or financing total. | ||||